Finding 1148415 (2024-004)

Significant Deficiency Repeat Finding
Requirement
P
Questioned Costs
-
Year
2024
Accepted
2025-07-25
Audit: 363060
Auditor: Bdo

AI Summary

  • Core Issue: Multiple fraud incidents were identified in PSI's federally funded programs across several countries, impacting financial integrity.
  • Impacted Requirements: Compliance with §200.516(a) mandates reporting known or suspected fraud, which PSI has adhered to by notifying the U.S. Office of the Inspector General.
  • Recommended Follow-Up: Continue leveraging the global internal audit team and fraud reporting mechanisms to strengthen fraud detection and prevention efforts.

Finding Text

Allegations of Fraud See Schedule of Findings and Questioned Costs for chart/table. Criteria: §200.516(a) Audit findings requires known or suspected fraud be reported by the auditor. Condition: During 2024, PSI identified multiple fraud incidents through its internal reporting mechanisms that impacted its federally funded programs. These fraud incidents have been reported to the appropriate U.S. Office of the Inspector General by PSI. • In Sierra Leone, records for mobile money batch payments to Community Health Workers were manipulated to divert payments to the wrong phone numbers. The total loss to award 7200AA18C00014 was $244 and to award 7200AA19CA00002 was $365. • In Cote d’Ivoire, a fraudulent invoicing system involving fraudulent service providers, suspicious use of billers and potential conflict of interests resulting in $8,221 of questioned costs to award 7206242CA00003. • In Angola, allegations regarding the improper receipt of per diem was substantiated. The total loss to award AID-654-A-17-00003 was $129. • In Mozambique, a whistleblower report revealed that a staff member had defrauded the Organization through the theft of cash payments made by staff remitting their federal sick leave salary refunds from the government. The total financial loss to award 72065622CA00009 was $174 and to award 7200AA20CA00007 was $102. • In Sierra Leone, a driver exaggerated mileage to cover for fuel payments that could not be accounted for and submitted falsified accommodation payment receipts. The total financial loss to award 7200AA19CA000032 was $106. • In Mali, an internal audit conducted on a subrecipient noted that there were differences in salaries charged to donor funds and actual salary received by the employees as well as fictitious competition and manipulation of expenses vouchers on behalf of the subrecipieint. The total financial loss to award 7200AA20CA00007 was $63,660. • In Zimbabwe, medical records were doctored and members of the public were bribed to misrepresent circumcision information. The total financial loss to award 72061318CA0009 was $41,307.50. PSI has ongoing investigations involving U.S. Federal funding pending in multiple countries for which the facts and circumstances and full effect of the fraud investigations have not been determined. Where investigations are still pending and conclusions of the matters identified through whistleblower or other communications have not been reached, PSI has reported such matters to the appropriate U.S. agency. Questioned Costs: There are no questioned costs as the questioned amounts have been, or are in the process of, being reimbursed to the respective Federal agency. Context: These conditions were identified through PSI’s internal review and audit processes and were reported to us during our internal control assessment for the year ended December 31, 2024. Cause: Individuals intentionally circumvented PSI’s established internal controls. Effect: These conditions could result in unallowable expenses being charged to U.S. Government awards if controls in place had not identified the conditions. Repeat Finding: The specific items identified above were not reported in the prior year; however, findings related to fraud were included for the prior year as findings 2023-004 in the December 31, 2023 schedule of findings and questioned costs. Recommendation: Because of the international environment in which PSI operates, the potential for fraud is heightened. Given this, we recommend management continue to utilize its global internal audit team and fraud reporting hotline, as well as other policies and procedures around fraud identification to mitigate the fraud risk. Views of Responsible Officials: PSI management agrees with the finding and recommendations set forth within and will proactively report and investigate allegations of fraud and to raise awareness of the actions to be taken when there is a suspicion of fraud. Refer to management’s correction action plan for additional information.

Categories

Procurement, Suspension & Debarment Subrecipient Monitoring Allowable Costs / Cost Principles Reporting Internal Control / Segregation of Duties

Other Findings in this Audit

  • 571964 2024-003
    Significant Deficiency Repeat
  • 571965 2024-004
    Significant Deficiency Repeat
  • 571966 2024-005
    Significant Deficiency Repeat
  • 571967 2024-004
    Significant Deficiency Repeat
  • 571968 2024-003
    Significant Deficiency Repeat
  • 571969 2024-002
    Significant Deficiency
  • 571970 2024-001
    Significant Deficiency Repeat
  • 571971 2024-004
    Significant Deficiency Repeat
  • 571972 2024-004
    Significant Deficiency Repeat
  • 571973 2024-004
    Significant Deficiency Repeat
  • 571974 2024-005
    Significant Deficiency Repeat
  • 571975 2024-004
    Significant Deficiency Repeat
  • 571976 2024-002
    Significant Deficiency
  • 571977 2024-004
    Significant Deficiency Repeat
  • 1148406 2024-003
    Significant Deficiency Repeat
  • 1148407 2024-004
    Significant Deficiency Repeat
  • 1148408 2024-005
    Significant Deficiency Repeat
  • 1148409 2024-004
    Significant Deficiency Repeat
  • 1148410 2024-003
    Significant Deficiency Repeat
  • 1148411 2024-002
    Significant Deficiency
  • 1148412 2024-001
    Significant Deficiency Repeat
  • 1148413 2024-004
    Significant Deficiency Repeat
  • 1148414 2024-004
    Significant Deficiency Repeat
  • 1148416 2024-005
    Significant Deficiency Repeat
  • 1148417 2024-004
    Significant Deficiency Repeat
  • 1148418 2024-002
    Significant Deficiency
  • 1148419 2024-004
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
98.001 Usaid Foreign Assistance for Programs Overseas $15.54M
98.U00 Usaid Cost Reimbursable Contracts and Other Awards $699,472
98.001 Covid 19 - Usaid Foreign Assistance for Programs Overseas $344,479
98.U00 Covid 19 - Usaid Cost Reimbursable Contracts and Other Awards $186,371
12.420 Military Medical Research and Development $73,012
12.350 Department of Defense Hiv/aids Prevention Program $35,605
93.067 Global Aids $-1,305